Description
PF-06939999 is a SAM-competitve inhibitor of PRMT5.
| Product Unit Size | Cost | Quantity | Stock |
|---|
PF-06939999 is a SAM-competitve inhibitor of PRMT5.
| Cas No. | 2159123-14-3 |
|---|---|
| Purity | ≥98% |
| Formula | C22H23F3N4O3 |
| Formula Wt. | 448.45 |
| IUPAC Name | (1S,2S,3S,5R)-3-[[6-(difluoromethyl)-5-fluoro-1,2,3,4-tetrahydroisoquinolin-8-yl]oxy]-5-(4-methylpyrrolo[2,3-d]pyrimidin-7-yl)cyclopentane-1,2-diol |
| Synonym | PF06939999; PRMT5-IN-3 |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Jensen-Pergakes K, Tatlock J, Maegley K, et al. SAM-competitive PRMT5 inhibitor PF-06939999 demonstrates antitumor activity in splicing dysregulated NSCLC with decreased liability of drug resistance. Mol Cancer Ther. 2022 Jan;21(1):3-15. PMID 34737197
BHA derivative.
Immunodominant peptide fragment of PLP, used to...
Endogenous APP peptide cleavage product, primar...
Mixture of kavalactones found in Piper methysti...
Dipeptide ester, commercial sweetener.
Natriuretic, vasodilatory peptide fragment; B1/...
Inhibitor of Abl, c-Kit, and PDGFR.
Corticosteroid
5-Nitroimidazole derivative; genotoxic.
Glycoside hydroquinone originally found in Berg...
Benzimidazole; microtubule polymerization inhib...
Triazole; 14-α demethylase and aromatase inhib...
Stem cell neurogenesis inducer.
Tamoxifen derivative; potential proteasome inhi...
Cyclic hexapeptide isolated from Phomopsis lept...
Ellagic acid derivative produced by gut microfl...
Smoothened agonist.
Triazole; 14-α demethylase inhibitor, voltage-...
Retinol (vitamin A) analog, binds RBP4; Des1 in...
GABA-A positive modulator.